drugset / Trial / NCT07660861

Remifentanil vs Esmolol During Intubation for Cerebral Aneurysm Coil Embolization

NCT07660861

RandomizedParallel-groupOpen-labelTreatment

Summary

Endotracheal intubation may cause significant increases in blood pressure, heart rate, and intracranial pressure, particularly in patients undergoing cerebral aneurysm coil embolization. Remifentanil and esmolol are commonly used agents to attenuate these responses during anesthesia induction. This randomized controlled trial aims to compare the effects of remifentanil and esmolol administered before endotracheal intubation on optic nerve sheath diameter/eyeball transverse diameter ratio (ONSD/ETD), a noninvasive surrogate marker of intracranial pressure, as well as hemodynamic responses in patients undergoing elective cerebral aneurysm coil embolization. The findings may help identify the most effective strategy for minimizing intubation-related intracranial pressure changes and hemodynamic fluctuations in neurointerventional anesthesia practice.

Timeline

Start
2026-06-22
Primary completion
2027-06-01
Completion
2027-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esmolol Other / unclassified 0.5 mg/kg Intravenous
Comparator Esmolol Other / unclassified 1 mg/kg Intravenous
Subject Remifentanil Small molecule 0.5 ug/kg Intravenous
Subject Remifentanil Small molecule 1 ug/kg Intravenous